NCT02293915: An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease |
|
|
| Completed | 3 | 818 | RoW | Sodium oligo-mannurarate 900mg, GV-971, Placebo | Shanghai Greenvalley Pharmaceutical Co., Ltd. | Mild to Moderate Alzheimer Disease, Cognitive Impairment | 06/18 | 09/18 | | |
